Skip to content

Trichomonas Vaginalis Recurrence Among HIV+ Women

Randomized Phase IV Trial of Metronidazole Single Dose Versus 7 Day Dose for Treatment of Trichomonas Vaginalis Among HIV-infected Women

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01018095
Enrollment
270
Registered
2009-11-23
Start date
2005-05-31
Completion date
2009-08-31
Last updated
2016-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections, Trichomonas Infections

Brief summary

The purpose of this study is to determine if the 2 gram single dose of metronidazole is as effective as the 7 day 500 mg BID dose for treatment of Trichomonas vaginalis (TV) among HIV-infected women.

Detailed description

This is a Phase IV equivalency trial as both doses of metronidazole are listed in the the Centers for Disease Control and Prevention Treatment Guidelines for the treatment of T vaginalis.

Interventions

DRUGMetronidazole

2 gm single dose versus 7 day 500 mg BID dose

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)
CollaboratorNIH
Tulane University Health Sciences Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Female * 18 years or older * HIV-positive * TV positive by either wet preparation or culture * ability to refrain from all alcohol use for 24 hours before and after taking oral metronidazole * willing to take metronidazole treatment

Exclusion criteria

* pregnant * incarcerated * previously enrolled * currently taking disulfiram * alcoholism or known liver damage * medical contraindications to metronidazole * treated with metronidazole within the previous 14 days * requires treatment for B.V. per Amsel's criteria

Design outcomes

Primary

MeasureTime frameDescription
TV Culture Positive Resulttest-of-cure visit at 6-12 days post-treatment completionAt the participants' test of cure (TOC) visits they were screened for Trichomonas vaginalis using (InPouch) culture. Presence of parasite will yield a culture positive result.

Secondary

MeasureTime frameDescription
TV Culture Positive Result3 months post-enrollmentParticipants who returned for their follow up visits were tested for Trichomonas vaginalis using InPouch culture. If parasites are present, it will yield a culture positive result.

Countries

United States

Participant flow

Recruitment details

HIV-infected women undergoing a routine gynecological examination performed by a clinic health care provider between May 1, 2006 and July 17, 2009 were tested for Trichomonas Vaginalis (TV) by culture as standard of care practice in selected public HIV outpatient clinics in New Orleans, Louisiana; Houston, Texas; and Jackson, Mississippi.

Participants by arm

ArmCount
7 Day Dose
Metronidazole : 2 gm single dose versus 7 day 500 mg BID dose
135
Single Dose
Metronidazole : 2 gm single dose versus 7 day 500 mg BID dose
135
Total270

Baseline characteristics

CharacteristicSingle Dose7 Day DoseTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
1 Participants0 Participants1 Participants
Age, Categorical
Between 18 and 65 years
134 Participants135 Participants269 Participants
Age, Continuous40.7 years
STANDARD_DEVIATION 9.4
39.5 years
STANDARD_DEVIATION 9.3
40.1 years
STANDARD_DEVIATION 9.4
Gender
Female
135 Participants135 Participants270 Participants
Gender
Male
0 Participants0 Participants0 Participants
Region of Enrollment
United States
135 participants135 participants270 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1350 / 135
serious
Total, serious adverse events
0 / 1350 / 135

Outcome results

Primary

TV Culture Positive Result

At the participants' test of cure (TOC) visits they were screened for Trichomonas vaginalis using (InPouch) culture. Presence of parasite will yield a culture positive result.

Time frame: test-of-cure visit at 6-12 days post-treatment completion

Population: Participants who returned for their test of cure visit

ArmMeasureValue (NUMBER)
7 Day DoseTV Culture Positive Result11 participants
Single DoseTV Culture Positive Result21 participants
Comparison: It was initially estimated that a total of 380 participants (190 per arm) would be required, with 90% power and a significance level of 5%, to establish equivalency between the two treatment arms.31 Enrollment rates were lower than estimated and only 270 participants (135 per arm) were enrolled.p-value: 0.04595% CI: [0.25, 1]Relative risk
p-value: <0.0595% CI: [0.21, 0.98]Chi-squared
Secondary

TV Culture Positive Result

Participants who returned for their follow up visits were tested for Trichomonas vaginalis using InPouch culture. If parasites are present, it will yield a culture positive result.

Time frame: 3 months post-enrollment

Population: Participants who returned for their 3 mo follow up visit

ArmMeasureValue (NUMBER)
7 Day DoseTV Culture Positive Result8 participants
Single DoseTV Culture Positive Result19 participants
Comparison: It was initially estimated that a total of 380 participants (190 per arm) would be required, with 90% power and a significance level of 5%, to establish equivalency between the two treatment arms.31 Enrollment rates were lower than estimated and only 270 participants (135 per arm) were enrolled.p-value: =0.0395% CI: [0.21, 0.98]Relative risk

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026